GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

Rating:
Outperform
AVII
up 251.06 %

Avi Biopharma, Inc. (AVII) rated Outperform with price target $4 by Wedbush

Posted on: Wednesday,  Apr 13, 2011  9:25 AM ET by Wedbush

Wedbush rated Outperform Sarepta Therapeutics Inc (NASDAQ: SRPT) on 04/13/2011, when the stock price was $10.32. Since
then, Sarepta Therapeutics Inc has gained 251.07% as of 01/19/2016's recent price of $36.23.
If you would have followed this Wedbush 's recommendation on SRPT, you would have gained 251.06% of your investment in 1742 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/13/2011 9:25 AM Buy
None
10.32 24.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy